🔎 Trials Near Me

홈 › 비소세포폐암 › 애리조나

애리조나의 비소세포폐암 임상 시험

비소세포폐암 관련 연구 66개가 애리조나 내 여러 지역에서 참여자를 모집하고 있습니다.

애리조나의 도시

공식 연구 텍스트(영어)

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

  • Banner Boswell Medical Center, Sun City
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT04267848

A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

  • Banner MD Anderson Cancer Center ( Site 0181), Gilbert
  • The University of Arizona Cancer Center - North Campus ( Site 0163), Tucson
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT06623422

Phase 1/2 Study of Intravenous Injection of STX-003 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab

  • HonorHealth Research Institute, Scottsdale
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT07751042

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

  • Exelixis Clinical Site #67, Phoenix
  • Exelixis Clinical Site #1, Tucson
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 1. 업데이트됨 · NCT05176483

A Platform Study in Non-Small Cell Lung Cancer (NSCLC)

  • Research Site, Phoenix
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 1. 업데이트됨 · NCT06996782

A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

  • Mohtaseb Cancer Center & Blood Disorders, Bullhead City
  • Palo Verde Hematology Oncology, Glendale
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT07361510

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

  • Palo Verde Hematology Oncology, Glendale
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT06765109

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

  • Research Site, Gilbert
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT05877599

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

  • Pioneer Research Center, Bullhead City
  • Ironwood Cancer & Research Centers, Chandler
  • Ironwood Cancer & Research Centers, Gilbert
  • 외 6개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07222566

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

  • Banner Health, Gilbert
  • Mayo Clinic Hospital, Phoenix
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT04981119

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

  • City of Hope Phoenix, Goodyear
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06667076

A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

  • Cancer Treatment Centers of America, Phoenix, Goodyear
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07154290

Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)

  • Mayo Clinic in Arizona - Phoenix ( Site 0147), Phoenix
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06170788

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

  • City of Hope, Phoenix, Phoenix
  • The University of Arizona Cancer Center - North Campus, Tucson
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT06890598

Pan-tumor MRD Study

  • Mohtaseb Cancer Center and Blood Disorders, Bullhead City
  • Cancer & Blood Specialists of Arizona, Casa Grande
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT06605404

A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%

  • Southern Arizona VA Health Care System, Tucson
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT06561386

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

  • Research Site, Tucson
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT06357533

A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

  • Ironwood Cancer and Research Center /ID# 276370, Chandler
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT06568939

Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors

  • Banner MD Anderson Cancer Center, Gilbert
  • Arizona Cancer Center at UMC North/University Medical Center, Tucson
피험자 모집 중1/2상
18세 ~ 99세 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT06814496

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

  • Research Site, Tucson
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 18. 업데이트됨 · NCT06692738

A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors

  • HonorHealth Research Institute, Scottsdale
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 18. 업데이트됨 · NCT07705334

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

  • Clinical Study Site, Chandler
  • Clinical Study Site, Phoenix
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 18. 업데이트됨 · NCT06767514

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

  • Banner Health- MD Anderson Cancer Center, Gilbert
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 16. 업데이트됨 · NCT05786924

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

  • Local Institution - 007-556-A, Goodyear
  • USOR - Arizona Oncology - Prescott Valley, Prescott Valley
  • Local Institution - 007-568-A, Safford
  • 외 5개
피험자 모집 중2/3상
18세 이상 · 모든 성별 · 2026. 9. 16. 업데이트됨 · NCT04613596

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

  • Ironwood Cancer & Research Centers, Chandler
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 9. 14. 업데이트됨 · NCT05059444

A Study of KK2269 in Adult Participants With Solid Tumors

  • Mayo Clinic Arizona, Scottsdale
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 10. 업데이트됨 · NCT06266299

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

  • City of Hope - Phoenix, Goodyear
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 8. 업데이트됨 · NCT06793215

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • Banner MD Anderson Cancer Center, Gilbert
  • Banner University Medical Center Phoenix, Phoenix
  • The University of Arizona Cancer Center - North Campus, Tucson
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 8. 업데이트됨 · NCT06119581

A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors

  • HonorHealth Research Institute, Scottsdale
  • Mayo Scottsdale, Scottsdale
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 4. 업데이트됨 · NCT07361562

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

  • HonorHealth, Scottsdale
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 4. 업데이트됨 · NCT06400472

Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations

  • Research Site, Chandler
  • Research Site, Gilbert
  • Research Site, Goodyear
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 4. 업데이트됨 · NCT07291037

Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion

  • Mayo Clinic, Phoenix
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT05245500

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

  • Mayo Clinic Arizona, Phoenix
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT07070232

A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer

  • Mayo Clinic Arizona, Phoenix
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 26. 업데이트됨 · NCT06892548

A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors

  • HonorHealth Research Institute, Scottsdale
피험자 모집 중1/2상
18세 ~ 75세 · 모든 성별 · 2026. 8. 19. 업데이트됨 · NCT07636785

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

  • Mayo Clinic Hospital in Arizona, Phoenix
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 8. 17. 업데이트됨 · NCT06500481

A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations

  • Mayo Clinic Hospital - Arizona, Phoenix
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 5. 업데이트됨 · NCT06706076

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

  • USOR HonorHealth, Phoenix
  • USOR Arizona Oncology Associates, Tucson
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 4. 업데이트됨 · NCT05579366

AOH1996 for the Treatment of Refractory Solid Tumors

  • Honor Health Research and Innovation Institute, Scottsdale
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 7. 28. 업데이트됨 · NCT05227326

A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation

  • Mayo Clinic Hospital, Phoenix
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 7. 22. 업데이트됨 · NCT06179160

ClinicalTrials.gov 출처, 2026. 10. 5. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.